ENGN · Forms 3, 4, 5
Insider trades at enGene Therapeutics Inc.
1 insider bought $10K of enGene Therapeutics Inc. stock on the open market in the last 30 days.
Every Form 3, 4 and 5 filed for enGene Therapeutics Inc. (ENGN) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.
Insider trades in the last 90 days
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| William Grossman | Interim Chief Medical Officer | Buy | 5,102 | $1.97 | $10K | Form 4 | |
| Constantine Chinoporos | Interim Chief Business Officer | Became an insider (Form 3) | Form 3 | ||||
| Kathleen P. Richton | SVP, Finance and Treasurer | Became an insider (Form 3) | Form 3 |
Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.